在患有心房的重症患者中凝血指数与死亡率之间的关联:一项回顾性研究
Zixi Huang1, Hualong Liu2, Fengchuan Huo2
1Department of General Practice, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
概括
凝血指数如PTT,PT/INR和纤维素与患有心房的重症患者的死亡率有关. 这项研究强调了它们对患者预后的价值.
科学领域:
- 危急护理医学
- 心脏病学
- 血液学
背景情况:
- 在患有心房的重症患者中,凝血指数的预后作用的证据有限.
- 了解这些关联对于改善患者管理和结果至关重要.
研究的目的:
- 在诊断为心房的重症患者中,研究关键凝血指数与死亡率之间的关联.
- 确定可预测该患者群体死亡风险的特定凝血参数.
主要方法:
- 使用了MIMIC- III数据库的数据,其中包括2284名患有AF的重症患者.
- 使用多变量校正分析来探索凝血指数 (PTT,PT/INR,纤维素) 和各种死亡终点 (医院,7天,30天,1年) 之间的关系.
主要成果:
- 在调整了混因子后,在PTT,PT/INR和纤维素水平与全因死亡率之间也观察到显著的正相关性 (P < 0. 001).
- 分层分析显示,性别影响了PTT死亡率的关联,而年龄,膜疾病,他类药物,肝素和阿司匹林影响了纤维素死亡率的关联.
结论:
- 这项研究提供了第一个累积的证据,证明PTT,PT/INR和纤维素水平与关键病患者的死亡率之间存在正相关性.
- 凝血指数是这一易受伤害的患者群体死亡率的重要预测指标,表明了潜在的干预目标.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K


